Amikacin Sulfate — Drug Intelligence | 10 EU Trials

Filter these 10 trials by condition, phase, country and more.

Open in Search →

10 Registered trials

3 Recruiting

2 Completed trials

5 Sponsors

10 Countries

Phase III

Phase II

Phase IV

Phase III: 5 Phase II: 2 Phase IV: 3

Indications tested

Antibiotic level therapeutic 1

Sponsors using this IMP

Assistance Publique Hopitaux De Paris 6 Centre Hospitalier Universitaire De Nantes 1 Meiji Seika Pharma Co. Ltd. 1 Tan Tock Seng Hospital Pte. Ltd. 1 Uppsala Universitet 1

All trials

10 total

Nebulized Amikacine for Ventilator associated gram negative Pneumonia in ECMO veno-arterial patients: A randomized Pilot Study (NAVAP-ECMO) Pending

2023-509722-22-00 Phase II 1 country Assistance Publique Hopitaux De Paris
Defining Antibiotic Levels in Intensive care patients (DALI-2) protocol Pending

2024-516232-10-00 Phase IV 1 country Centre Hospitalier Universitaire De Nimes
BICCS - Beta-lactam Intermittent versus Continuous infusion and Combination antibiotic therapy in Sepsis Pending

2024-516849-39-01 Phase III 1 country Assistance Publique Hopitaux De Paris
3-day intravenous antibiotic treatment versus 3-day intravenous followed by 7-day oral antibiotic treatment for acute pyelonephritis in chil… Pending

2024-518930-10-00 Phase III 1 country Assistance Publique Hopitaux De Paris
Optimal Duration of Antibiotic Therapy in Drained Pyogenic Liver Abscess: 3 weeks versus 6 weeks, a non-inferiority trial Pending

2025-520940-14-00 Phase IV 1 country Assistance Publique Hopitaux De Paris
Pivmecillinam as oral step-down treatment for Escherichia coli febrile urinary tract infection versus standard of care; a randomized control… Recruiting

2023-503447-33-00 Phase II 2 countries Uppsala Universitet
Randomized open-label controlled trial evaluating a single-dose intravenous Dalbavancin versus standard antibiotic therapy during catheterre… Recruiting

2024-514952-34-00 Phase III 1 country Assistance Publique Hopitaux De Paris
Combination lock01 - Impact of aminoglycosides-based antibiotics combination and protective isolation on outcomes in critically-ill neutrope… Recruiting

2024-514042-36-00 Phase III 1 country Assistance Publique Hopitaux De Paris
Comparison of continuing intravenous antibiotic therapy with switching to oral antibiotics in clinically stable patients with blood infectio… Ended

2024-517308-13-00 Phase IV 3 countries Tan Tock Seng Hospital Pte. Ltd.
Study to Assess the Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy in Adults With Complic… Ended

2024-515180-56-00 Phase III 7 countries Meiji Seika Pharma Co. Ltd.

Showing 1–10 of 10 trials

← All drugs A–Z